See also this year's filing and all EDGAR filings for this company.
PDF Report 0001534248_2023_Chemomab_Therapeutics_Ltd.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001534248, Chemomab Therapeutics Ltd.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 41,736,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 367,000 |
| 3 | remainder_Assets | 960,000 |
| 4 | LiabilitiesCurrent | 6,749,000 |
| 5 | LiabilitiesNoncurrent | 91,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,556,000 |
| 9 | ResearchAndDevelopmentExpense | 16,977,000 |
| 10 | remainder_Expenses | -534,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 353,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 43,063,000 |
| 1 | Liabilities | 6,840,000 |
| 2 | Expenses | 27,999,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 36,223,000 |
| 5 | NetIncome | -27,646,000 |
| 6 | ComprehensiveNetIncome | -27,646,000 |
| 7 | BaseVar | 39,127,500 |
| 8 | EconomicCapitalRatio | 1.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
